<DOC>
	<DOCNO>NCT01847495</DOCNO>
	<brief_summary>The purpose study determine effect CyberKnife stereotactic body radiotherapy combination irinotecan chemotherapy patient colon rectal cancer spread liver . Conventional radiation therapy limited role treatment patient liver metastasis radiation dos limit liver toxicity . The CyberKnife system type radiation machine precisely focus large dos x-rays tumor , injury radiation nearby normal tissue minimal . It approve U.S. Food Drug Administration treat tumor , lesion condition anywhere body radiation therapy require . While device longer classify `` investigational '' , best treatment dose time still evaluate . Chemotherapy deliver radiation therapy increase effectiveness treatment , may allow low dose radiation therapy utilized , thereby limit negative side effect . In study , patient receive Cyberknife radiosurgery direct liver metastasis 3-5 treatment , give every day . Irinotecan 40mg/m2 administer intravenously daily 3-5 day ( 5 treatment within 10 elapsed day ) , prior radiation therapy . Patients follow-up visit month 1,2,4,6,9,12,15,18 , 24 , 30 , 36 , every 6 month thereafter 3 year .</brief_summary>
	<brief_title>Evaluation Low-dose Irinotecan CyberknifeÂ® SBRT Treat Colorectal Cancer With Limited Liver Metastasis</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Age &gt; 18 year Histologically confirm primary colorectal cancer Stage IV colorectal cancer &lt; /= 3 metastasis , 5cm size . CT scan MRI abdomen contrast , 60days prior enrollment If patient allergic contrast , image without contrast acceptable PositronEmission Tomography 60 day prior enrollment No additional site metastasis time protocol enrollment . History sit metastasis currently control acceptable . No malignant ascites At least 4 week chemotherapy No prior liver radiation therapy ECOG performance status 01 Life expectancy &gt; 3months Laboratory evaluation complete 60 day prior treatment include CMP , CBC differential , liver function test , prothrombin time .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Stage IV Colorectal Carcinoma</keyword>
	<keyword>Liver metastasis</keyword>
	<keyword>Cyberknife</keyword>
	<keyword>Stereotactic Body Radiotherapy</keyword>
	<keyword>SBRT</keyword>
	<keyword>Irinotecan HCl</keyword>
	<keyword>CPT-11</keyword>
</DOC>